Date:March 04, 2026
Bio Usawa was honored to be received by Dr. Ivan Butera, Rwanda’s Minister of State for Health, this week to share updates on the company's progress and strategic priorities for 2026.
Kigali is home to Bio Usawa’s first manufacturing hub on the continent and we appreciate the Ministry of Health’s continued engagement as new capabilities take root in the country.
Honourable Dr. Butera reiterated that the Ministry stands ready to support and encouraged closer coordination through the appropriate government channels.
Bio Usawa remains committed to working hand in hand with stakeholders, both public and private, to contribute to a stronger, more resilient health system for the region.

Bio Usawa celebrates the extraordinary vision and leadership of the African Diaspora Network (ADN) and expresses deep appreciation for this year’s Afric…
March 2026In the first half of 2026, Bio Usawa will open Sub-Saharan Africa’s first GMP-compliant monoclonal antibodies manufacturing facility in Rwanda — a histo…
March 2026Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical stabilization, today announced a defi…
February 2026